|
EDSA Edesa Biotech Inc 1540159 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-4,218,332.00 |
| Balance Sheet |
|
Current Assets
|
$10,417,727.00 |
|
Assets
|
$12,384,738.00 |
|
Current Liabilities
|
$2,187,921.00 |
|
Liabilities
|
$1,832,827.00 |
|
Equity
|
$10,196,817.00 |
|
Shares Out
|
8885719.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,103,956.00 |
| Market Analysis |
Market Cap
|
$46,650,024.75 |
|
Price
|
$4.86 |
|
BVPS
|
1.15 |
|
PB
|
4.57 |
|
EPS
|
-0.49 |
|
FCF
|
$-4,103,956.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:38 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EDSA documents filed with the SEC.
EDSA Filings
Clear
